These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 36620648)

  • 1. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H; Zhu Y; Shen G; Wang Z; Li W
    Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N; Qi X; Dang Y; Li Y; Wang G; Liu X; Zhu N; Fu J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):513. PubMed ID: 33297955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.
    Wang Z; Peng J
    Sci Rep; 2023 Mar; 13(1):5084. PubMed ID: 36977721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z; Xu Y; Tang L; Wu M; Wu B; Zhu T; Wang J
    Cardiovasc Diabetol; 2023 Apr; 22(1):87. PubMed ID: 37055777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of platelet/lymphocyte ratio and CAMI-STEMI score for major adverse cardiac events in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: A prospective observational study.
    Wang Y; Peng Z
    Medicine (Baltimore); 2021 Aug; 100(33):e26942. PubMed ID: 34414954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.
    Liu HW; Han YL; Jin QM; Wang XZ; Ma YY; Wang G; Wang B; Xu K; Li Y; Chen SL
    Chin Med J (Engl); 2018 Jun; 131(12):1412-1419. PubMed ID: 29893357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.
    Wang Y; Liu L; Li X; Dang Y; Li Y; Wang J; Qi X
    J Interv Cardiol; 2022; 2022():8994106. PubMed ID: 35356419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.
    Zhu H; Li Z; Xu X; Fang X; Chen T; Huang J
    PeerJ; 2020; 8():e9068. PubMed ID: 32355581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Eur Radiol; 2021 Feb; 31(2):1140-1150. PubMed ID: 32856164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.
    Wang Y; Wang W; Jia S; Gao M; Zheng S; Wang J; Dang Y; Li Y; Qi X
    BMJ Open; 2022 Feb; 12(2):e056101. PubMed ID: 35110324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.
    Yang L; Cong H; Lu Y; Chen X; Liu Y
    Ann Transl Med; 2021 Jan; 9(2):126. PubMed ID: 33569428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and prediction nomogram model for 1-year readmission for major adverse cardiovascular events in patients with STEMI after PCI.
    Yao W; Li J
    Clin Appl Thromb Hemost; 2022; 28():10760296221137847. PubMed ID: 36380508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selected cardiovascular factors on mortality in patients with ST-segment elevation myocardial infarction treated with primary coronary intervention.
    Komorova Z; Machal J; Groch L; Spinarova L; Labr K
    Bratisl Lek Listy; 2023; 124(6):421-426. PubMed ID: 36876376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central arterial pressure predicts in-hospital major adverse cardiovascular events after acute ST-segment elevation myocardial infarction: a retrospective cohort study.
    Zhang L; Wang Z; Lu X; Gan F
    Ann Transl Med; 2023 Mar; 11(5):214. PubMed ID: 37007547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study.
    Qin Z; Du Y; Zhou Q; Lu X; Luo L; Zhang Z; Guo N; Ge L
    Cardiol Res Pract; 2021; 2021():9943668. PubMed ID: 34765262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
    Kong S; Chen C; Zheng G; Yao H; Li J; Ye H; Wang X; Qu X; Zhou X; Lu Y; Zhou H
    BMC Cardiovasc Disord; 2021 May; 21(1):253. PubMed ID: 34022791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.